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Abstract. Since in juvenile rats the liver is the predomi- 
nant site of erythropoietin (EPO) gene expression, we 
have used primary cultures of juvenile rat hepatocytes to
establish an in vitro system for investigation of oxygen- 
dependent EPO formation. When isolated hepatocytes 
were incubated at reduced oxygen tensions for 18-48 h, 
we found increased secretion of EPO protein and elev- 
ated levels of EPO mRNA, as determined by RNase pro- 
tection. This increase was maximal at 3% 02, where 
EPO mRNA levels after 18 h were approximately 15- 
fold higher than at 20% 02. The increase in EPO mRNA 
at low oxygen tensions was specific insofar as [3H]urid- 
ine incorporation, as a measure of total RNA synthesis, 
was reduced by approximately 50% at 3% 02, and it 
appeared to involve gene transcription since it was abol- 
ished in the presence of actinomycin D (35 taM). Signifi- 
cant increases in EPO mRNA were also observed in 
cells kept at 20% oxygen in the presence of cobalt chlor- 
ide (50 pM) and nickel chloride (400 ~tM), but EPO 
mRNA levels achieved under these conditions were less 
than 7% of those in cells incubated at 3% oxygen. No 
increase in EPO mRNA levels was observed in cultures 
incubated at 20% 02 in the presence of cyclic dibutyryl- 
AMP (10 pM-3  raM), cyclic 8-bromoGMP (10 pM-  
1 raM), cyclohexyladenosine (1 ~tM), 5'-N-ethylcarbox- 
amidoadenosine (1 gM) and phorbol 12-myristate 13- 
acetate (3 nM). In the presence of 10% carbon monox- 
ide, used to block haem proteins in their oxy confor- 
mation, EPO mRNA levels in hepatocytes incubated at 
low oxygen tensions were reduced to 63%. Taken to- 
gether, these findings indicate that oxygen-dependent 
control of the EPO gene in hepatocytes operates via in- 
trinsic cellular oxygen-sensing mechanisms. Their signal 
transduction does not seem to occur via classical "se- 
cond-messenger" pathways. A haem protein may be in- 
volved in oxygen sensing, but no conclusive vidence 
was obtained as to whether it is essential. 
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Introduction 
Production of erythropoietin (EPO), the major regulator 
of erythropoiesis, is inversely related to oxygen avail- 
ability of the organism [17]. Kidneys and liver are the 
physiologically important production sites of EPO and 
in both organs the major control of EPO formation has 
been shown to operate at the level of its mRNA [2, 4, 
31]. EPO mRNA was detected in peritubular cells of the 
renal cortex [18, 22] and recently in parenchymal s well 
as non-parenchymal liver cells [19, 33]. Changes in EPO 
mRNA are at least in part mediated through changes in 
the EPO-transcription rate [32], and analysis of human 
EPO gene expression in transgenic mice revealed that a 
sequence within the immediate 3' flanking region of the 
gene is required for expression in hepatocytes, and that, 
in addition, a region between 6 and 14 kb 5' of the gene 
directs expression in the kidneys [34]. 
Little is known, however, about the cellular mecha- 
nisms by which hypoxia controls the expression of the 
EPO gene. Efforts to explore these mechanisms have in 
the past been hindered by the lack of in vitro systems 
producing EPO in a regulated fashion. The significance 
of studies in various systems uch as organ cultures of 
rat kidney [23, 25, 37] or mouse fetal liver [44], isolated 
glomeruli [5], renal mesangial cell cultures [20], renal 
tubular cell lines [6, 36], erythroleukaemic cells [3, 39], 
mouse spleen macrophages [28], fetal liver cells [21] 
and isolated Kupffer cells [26] remains difficult to inter- 
pret mainly for two reasons. First, demonstration f EPO 
production in these systems depended upon bioassays 
and/or inhibition of bioactivity by antibodies raised 
against impure preparations of EPO and, second, many 
of the cell types claimed to produce EPO have not been 
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shown to express the EPO gene in vivo. More recently, 
Goldberg et al. [13] and subsequently other investigators 
[8, 41] reported the regulated expression of  the EPO 
gene and production of  EPO protein in the two human 
hepatoma cell lines Hep G2 and Hep 3B in response to 
hypoxia and certain divalent metals, which are known 
stimuli for EPO formation in vivo [15]. Moreover, cir- 
cumstantial evidence was provided that the oxygen 
sensor regulating EPO in Hep 3B cells is a haem protein 
[14]. 
For further study of  the oxygen-dependent control of  
EPO formation we attempted to establish an in vitro sys- 
tem using cells that are physiological production sites of  
EPO in vivo. Such a system should allow us to define 
the cellular characteristics of  the oxygen-dependent con- 
trol of  EPO in vivo and should also allow the signifi- 
cance of findings so far obtained in tumor cell lines to 
be tested. Recently we have shown that, in contrast o 
what was previously anticipated, in rats the contribution 
of  the liver to EPO formation under severe hypoxia is 
quite significant and amounts to about one-third in ad- 
ults and to 80%-90% up to an age of  2 weeks [12]. We 
have therefore focussed on hepatic EPO formation and 
report here that fractionation of  liver cells from hypoxic 
juvenile rats indicates that, as in adult animals [19, 33], 
hepatocytes are the major site of  EPO gene expression 
in the liver, and, furthermore, that in hepatocytes i olated 
from normoxic juvenile animals, accumulation of  EPO 
mRNA is inducible in vitro by hypoxia. 
Materials and methods 
Animals. Male Sprague Dawley rats aged 10-19 days (body 
weight 30 _+ 2 g; mean _+ SE) were used (Charles River Wiga, 
Sulzbach, Germany). 
Liver cell isolation. Cells were isolated from livers using a two- 
stage in situ perfusion via the portal vein [1] in a non-recirculating 
system. The basic perfusion medium consisted of Hanks buffered 
salt solution (HBSS; 137raM NaC1, 3.YmM KC1, 0.4raM 
KH2PO4, 0.3 mM Na:HPO4, 4 rnM NaHCO3, 5.5 mM glucose) and 
was supplemented with 10 mM HEPES, 0.5 mM EGTA (medium 
1) or with 10 mM HEPES, 5 mM CaC12, 0.1 mg/ml collagenase 
(0.287 U/mg, Boehringer Mannheim, Mannheim, Germany) (me- 
dium 2). After cannulation of the portal vein, livers were flushed 
with l ml sodium heparin (1000 U/ml) then perfused with medium 
1 for 5 min at a rate of 4.5 ml/min and subsequently with medium 
2 for 8 min at a rate of 3.8 ml/min. Perfusion media were preoxy- 
genated and prewarrned to 37 ~ C. After excision, livers were im- 
mediately placed in ice-cold HBSS and cells were gently liberated 
into the buffer after opening of the liver capsule. The suspension 
was cleared of the connective tissue framework and remaining 
clumps of tissue by filtration through a 50-pm nylon sieve. 
Differential centrifugation of liver cells. Fractions of parenchymal 
and non-parenchymal liver cells were prepared from animals ex- 
posed to 7% 02 for 7 h prior to liver cell isolation using differential 
centrifugation, exactly as described by Doolittle and Richter [10]. 
Fractionation was carried out at 4 ~ C and comprised five centrifug- 
ation steps at 50 g to pellet hepatocytes and four centrifugations 
of the supernatant a 500 g, alternating with four at 50 g to pellet 
non-parenchymal liver cells and remove residual hepatocytes. 
One-third of the single-cell suspension used as starting material 
was removed prior to separation, kept at 4 ~ C during the separa- 
tion, and snap-frozen i  liquid nitrogen together with aliquots of 
the parenchymal nd non-parenchymal fraction prior to RNA ex- 
traction. 
Cell culture. After isolation and two washes at 90 g in ice-cold 
HBSS, cells were suspended in minimal essential medium (Gibco 
BRL, Life Technologies, Eggenstein, Germany), supplemented 
with 10% fetal bovine serum (Gibco), glutamine (2 raM), penicil- 
lin (50 units/ml), streptomycin sulphate (50 gg/ml), insulin (10 gg/ 
ml) and hydrocortisone (2gg/ml) and were routinely plated at a 
density of (8-11)X104 cells/cm 2 in 175-cm 2 dishes. After 4 h in- 
cubation at 20% 02/5% COJ75% N> to allow cell attachment, the 
culture medium was removed together with the majority of non- 
attached cells, which consistently comprised less than 10%, and 
cultures were refed the same medium without serum supplemen- 
tation. Subsequent incubation was carried out for 18-48 h at 1%, 
2%, 3%, 5% or 20% OJ5% COJbalance N2 in waterjacketed in- 
cubators (models 3319 and 3336, Forma Scientific, Marietta, Ohio 
45750, USA). Oxygen tensions in the incubators were verified 
using an oxygen electrode (Eschweiler, Kiel, Germany). Six to 
eight dishes were prepared from the cells isolated from one animal 
and in each experiment at least one dish was always kept at 3% 
02 and 20% 02, thus providing internal controls for the different 
conditions tudied. In pharmacological studies ubstances were ad- 
ded to the serum-free culture medium as follows: COC12 (10- 
100 gM), NiC12 (50-400 gM), MnCI2 (50-600 gM), 8-bromogu- 
anosine cyclic 3',5'-monophosphate (0.01-1 raM), N-2'-O-dibu- 
tyryladenosine cyclic 3',5'-monophosphate (0.01-3 raM), forsko- 
lin (10 gM), N-cyclohexyladenosine (1 gM), 5'-N-ethylcarboxami- 
doadenosine (1~tM), phorbol 12-myristate 13-acetate (3 nM), acti- 
nomycin D (35 buM). Cycloheximide (200 ~tM), 4,6-dioxohep- 
tanoic acid (2 mM) and desferrioxamine (130 gM) were added ur- 
ing both preincubation with serum-containing medium and sub- 
sequent incubation in serum-free medium. In experiments with the 
latter two drugs, cells were preincubated for 24 h instead of 4 h. 
In a separate set of experiments designed to test the effect of 
carbon monoxide on EPO gene expression i  hepatocyte cultures, 
cells were plated in 175-cm z flasks which were, after 4 h preincu- 
bation and change of medium, fitted tightly with a stainless-steel 
lid. Gas in- and outflow were provided by two steel tubes, which 
perforated the lid and were connected to two Silastic tubings at 
the outside of the flask. The flasks were flushed with premixed 
gases containing either 1% 02, 5% CO2, balance N2 or 1% 02, 5% 
CO2, 10% CO, balance N2, and, after the silastic tubings were 
sealed, the flasks were immersed in a 37 ~ C constant-temperature 
water bath for 18 h. At the end of the incubation the tight seal of 
the flasks was verified by measuring the oxygen tension inside. 
Measurement of EPO mRNA. Cells were harvested with trypsin/ 
EDTA, snap-frozen i liquid nitrogen and stored at -70 ~ C prior 
to RNA extraction. RNA was prepared using a modified single- 
step acid/guanidinium thiocyanate/phenol/chloroform extraction 
method (RNAzol B, Biogenesis, Bournemouth, England) and was 
assayed by RNase protection as described [27]. RNA probes were 
continuously abelled with [a-32p]GTP (410 Ci/mmol; Amersham 
International, Amersham, UK) by SP6 polymerase, using a ge- 
nomic rat EPO DNA template, which comprised a PstI-SacI frag- 
ment, containing 132 base pairs (bp) of exon V and approximately 
300 bp of the adjoining intron. Between 44 gg and 150 gg total 
RNA was hybridized with (0.25-0.5)• radiolabelled 
EPO probe in 80% formamide/40 mM 1,4-piperazinediethanesul- 
phonic acid (PIPES), pH 6.4/400 mM NaC1/1 mM EDTA at 60 ~ C 
overnight, and RNase digestion was performed at 20~ for 30 
min. Protected fragments were subjected to denaturing polyacryla- 
mide gel electrophoresis and quantified by measuring the radioac- 
tivity of excised portions of the dried gel in liquid scintillant (1500 
Tri-Carb liquid Scintillation Analyzer, Packard Instrument Com- 
pany, Downers Grove, IL 60515, USA). Equivalent amounts of 
yeast ransfer RNA were run in each assay to assess background 
radioactivity. After background subtraction the radioactivity of 
each protected EPO mRNA fragment was divided by the quantity 
of total RNA analysed and expressed relative to an external stan- 
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dard, as described [12], consisting of I gg pooled RNA extracted 
from kidneys of severely anaemic adult rats, which was coanalysed 
with each gel and assigned an arbitrary value of 1. 
Determination fcell viability. Trypan blue exclusion was used as 
a parameter of cell viability. Aliquots of the suspension of freshly 
isolated cells in culture medium (500 gl) were incubated together 
with 40 gl phosphate-buffered saline (PBS) and 360gl trypan blue 
stock solution (0.5% in 0.9% NaC1; Seromed, Berlin, Germany) 
for 3 rain at 37 ~ C and immediately thereafter the percentage of
cells excluding the dye was counted under an inverted microscope 
using a standard counting chamber. To assess changes in viability 
of cultured cells, hepatocytes were incubated in 9.6-cm 2 dishes 
under conditions identical to those used for measurement of EPO 
mRNA. At the end of the 4-h preincubation period or after 18 h 
of subsequent incubation at 3% or 20% oxygen, the culture me- 
dium was removed, and the cells were incubated with 540 ~tl PBS 
and 360 gl trypan blue stock solution for 3 min at 37 ~ C. After 
removal of the supernatant the percentage of cells excluding the 
dye was directly counted in the culture dishes. 
Measurement of total RNA synthesis. [3H]Uridine incorporation 
into trichloroacetic-acid(C13AcOH)-insoluble mat rial was used as 
a measure of total RNA synthesis as described [43], in cultures 
that were incubated under conditions identical to those used for 
measurement of EPO mRNA, except hat 9.6-cm ~ dishes were 
used. In brief, 0.1 gCi [5-3H]uridine (28 Ci/mmol, Amersham) was 
added to the dishes during the final 2.5 h of incubation at 3% or 
20% oxygen. At the end of the incubation period the culture dishes 
were immediately transferred to a cold room. The cells were rinsed 
with I ml ice-cold PBS, and the cell layers were covered with 3 ml 
ice-cold C13AcOH (10%) to extract C13AcOH-soluble nucleosides/ 
nucleotides in situ at 4~ for 50 rain. After washing the cells 
three times with cold C13AcOH (10%), they were dried at room 
temperature and digested in t ml 1 M KOH. Radioactivity was 
counted in liquid scintillant after neutralization with 1 M HC1. 
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Fig. 1. Erythropoietin (EPO) mRNA in an initial, freshly isolated 
single-cell suspension of juvenile rat liver cells (/) and in fractions 
of parenchymal (P) and non-parenchymal (NP) liver cells, pre- 
pared from the initial cell suspension by differential centrifugation. 
Left: autoradiograph of an RNase protection assay from one cell- 
separation experiment using 44 gg RNA from each cell fraction 
and 1 ~tg kidney RNA as external standard (std). Right: quantita- 
tive analysis ofEPO mRNA concentrations i  initial (/), parenchy- 
mal (P) and non-parenchymal (NP) cell suspensions in three inde- 
pendent experiments (mean _+ SE). For quantification, the radioac- 
tivity of protected EPO mRNA fragments was determined after 
excision from the dried gels, and was related to that of 1 gg renal 
RNA from severly anaemic rats, which was coanalysed on each 
gel and assigned an rbitrary value of 1, to obtain estimates of the 
concentration f EPO mRNA per microgram total RNA analysed. 
Prior to cell isolation animals were exposed to7% O~ for 7 h 
Results 
Measurement ofprotein synthesis. In a separate set of experiments 
protein synthesis was measured inparallel in insolated rat hepato- 
cytes and the human hepatoma cells Hep G2, which were seeded 
in 9.6-cm 2 dishes at identical densities. Cells were incubated for 
18 h in basal Eagle's medium without L-methionine (Gibco), sup- 
plemented with 10% fetal calf serum and 1.5 gCi/dish 35S-labelled 
L-methionine (> 1000 Ci/mmol; Amersham) in the absence and 
presence of COC12 (50 gM). Cell layers were treated as described 
for measurement of RNA synthesis to determine incorporation of
labelled methionine into C13AcOH-insoluble material. Incorpora- 
tion of [35S]methionine was related to cellular protein content. To 
this end the culture medium in parallel cultures was removed and 
after two washes of the cell layers with PBS, cells were lysed in 
1 ml PBS supplemented with 0.1% Triton X-100. Protein concen- 
trations of cell lysates were determined with a commercially avail- 
able protein assay (Bio-Rad) using bovine serum albumin as stan- 
dard. 
Measurement ofEPO. EPO concentrations i  tissue-culture super- 
natants, that were concentrated up to 15-fold by ultrafiltration 
(Centrisart I, SM 13249, Sartorius, G6ttingen, Germany) were 
measured by radioirnmunoassay as described [11], using a pool of 
serum from hypoxic rats as tandard after calibration i the in vivo 
bioassay [11]. 
Agents. Unless otherwise indicated agents were from Sigma 
(Sigma Chemical Company, St. Louis, MO 63178, USA). 
Statistics. Student's paired t-test was used for comparison f EPO 
mRNA levels in culture dishes obtained from the same cell prep- 
aration, which were incubated and analysed in parallel. Scheffe's 
test (analysis of variance) was used to compare EPO mRNA levels 
in cultures that were not processed in parallel. P < 0.05 was 
considered significant. 
Differential centrifugation of liver cells 
obtained from hypoxic rats 
When viewed by phase-contrast microscopy freshly iso- 
lated liver cells appeared as a well-dissociated hetero- 
geneous population, in which non-parenchymal cells 
could be differentiated from the much larger, occasion- 
ally binucleate hepatocytes. In accordance with previous 
studies [10, 42] differential centrifugation of the liver 
cell suspension resulted in a virtually pure fraction of 
hepatocytes, in which hardly any smaller cells could be 
detected, and a second fraction, significantly enriched in 
smaller, non-parenchymal cells. Using two-thirds of the 
cells isolated from one liver as starting material, the 
yield of total RNA in the parenchymal fraction was 
994-+ 137gg and in the non-parenchymal fraction 
58 _+ 6.1 gg (mean ___ SE, n = 3). As shown in Fig. 1, 
when equal amounts of RNA were assayed for the pres- 
ence of EPO mRNA, similar signals were obtained in 
the initial cell suspension, the parenchymal nd the non- 
parenchymal fraction. Although the non-parenchymal 
fractions showed 20%-30% contamination with hepa- 
tocytes, as estimated by differential counting using an 
inverted phase-contrast microscope, this could not ac- 
count for an EPO mRNA level as high as in the paren- 
chymal cells alone, suggesting that EPO mRNA is pre- 
sent in both hepatocytes and non-parenchymal liver 
cells. Considering, however, that removal of non-paren- 
chymal cells from the starting material did not result in 
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Fig, 2, EPO mRNA levels in primary cultures of rat hepatocytes 
(mean _+ SE). After isolation cells were preincubated for 4 h at 
20% Oz in the presence of 10% fetal calf serum. Cell culture 
medium was then replaced by serum-free medium, thereby remov- 
ing non-attached cells. Subsequently (start of the experiment) cul- 
tures were incubated for a further 18 h at 20% or 3% O2. EPO 
mRNA was quantified by RNase protection as described in Ma- 
terials and methods and the legend of Fig. t. EPO mRNA levels 
at the end of the preincubation period and after incubation at 20% 
oxygen during the subsequent 18 h were significantly ower than 
in cultures incubated at 3% oxygen for 18 h 
a significant reduction of the abundance of EPO mRNA 
(parenchymal versus initial fraction), and taking into ac- 
count that approximately 17 times more RNA was ex- 
tractable from the parenchymal cell fraction than from 
the non-parenchymal ce l fraction, it would appear that 
the majority of EPO mRNA in the liver of juvenile rats 
was present in hepatocytes. This is in accordance with 
the situation i adult animals, in which a recent study, 
using in situ hybridization and also cell fractionation 
[33], provided similar conclusions. For subsequent in vi- 
tro studies we therefore used established conditions pro, 
moting the culture of hepatocytes, i. e. low-speed centri- 
fugation for cell harvest, change of medium to remove 
non-attached non-parenchymal cells and, except where 
otherwise indicated, serum-free maintenance onditions. 
EPO mRNA levels in cultured hepatocytes 
When hepatocytes obtained from normoxic animals 
were incubated in vitro, different levels of EPO mRNA 
were observed, depending on oxygen concentrations in 
the incubator. As shown in Fig. 2, EPO mRNA was 
readily detectable in cultures after the 4-h preincubation 
at 20% 02. During the additional 18-h incubation at 20% 
02, EPO mRNA levels declined. In fact, in many single 
cultures kept at 20% O= for this period, EPO mRNA 
became undetectable with the assay conditions used. 
Average standardized values of labelled EPO mRNA, 
however, were slightly above the background level 
(P < 0.005) and comparison of the mean EPO mRNA 
levels before and after an 18-h incubation allowed an 
estimate of the mean reduction, which was 4.5-fold. In 
contrast, when cultures were kept at 3% O2 for 18 h, 
EPO mRNA markedly increased, so that average levels 
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Fig. 3. EPO mRNA levels in primary cultures of rat hepatocytes 
incubated for 18 h at different oxygen tensions (mean +_ SE). In- 
sert shows autoradiograph of an RNase protection assay after 3 
days exposure and illustrates an example of the signals obtained 
with 125 gg RNA extracted from cultures incubated at 2%-20% 
02. std, protected fragment of a l-gg aliquot of renal RNA that 
was coanalysed on the gel. EPO mRNA is expressed relative to 
this external standard s escribed in Materials and methods and 
the legend of Fig. 1. EPO mRNA levels in cultures incubated at 
t % and 2% oxygen were significantly ower than those in cultures 
of the same cell preparation i cubated in parallel at 3% O2 
(P < 0.05 and P < 0.03 respectively) 
of EPO mRNA after 18 h were 15 times higher in cul- 
tures kept at 3% O2 as compared to cultures kept at 20% 
02. Supplementation f medium with 10% fetal calf 
serum did not change EPO mRNA levels, as compared 
to parallel cultures incubated under serum-free con- 
ditions (not shown). 
Figure 3 illustrates EPO mRNA levels in hepatocytes 
incubated for 18 h at different oxygen tensions and 
shows that EPO mRNA levels were maximal at around 
3 % O2 in the incubator, while less and more severe hy- 
poxia resulted in somewhat lower EPO mRNA concen- 
trations. 
Cell viability, as assessed by trypan blue exclusion, 
was 92 + 3.7% in freshly isolated cells and 83 + 4.0% 
after 4 h of preincubation at20% O2 (mean -+ SE, n = 
3). The percentage of cells excluding trypan blue after 
18 h of incubation at 20% and 3% 02 was 83 _+ 2.4% 
and 82 +_ 3.8% respectively (mean +_ SE, n = 3) and 
thus not affected by the reduction in oxygen tensions. 
Total RNA synthesis, however, as assessed by measure- 
ment of [3H]uridine incorporation i to C13AcOH-insol- 
uble material during the final 2.5 h of incubation, was 
74% and 56% lower respectively in cultures kept at 1% 
and 3% 02 than in cultures kept at 20% 02 (313 _+ 14 
and 534 + 9 cpm/dish compared to 1204 + 22 cprrd 
dish; mean _+ SE, n = 6). 
To test if the hypoxia-induced accumulation of EPO 
mRNA was dependent on gene transcription, cultures 
were incubated at 3 % 02 in the presence of actinomycin 
D (35 btM). Addition of actinomycin D virtually abol- 
ished the rise in EPO mRNA [EPO mRNA/l.tg total 
RNA (• 10-4): 296 + 0.72 versus 21.7 _+ 5.2 in parallel 
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Fig. 4. Radioimmunoassay: dose/response curve for rat EPO (O) 
and serial dilutions of concentrated culture medium from primary 
cultures of rat hepatocytes incubated at 3% (O) or 20% O2 (A) 
for 48 h. Concentration factors are given below and above the 
respective curve. B/Bo indicates binding of radiolabelled human 
EPO to the antiserum in the respective sample in relation to bind- 
ing in the absence of unlabelled EPO (Bo) 
cultures incubated at 3 % 0 2 in the absence of the drug; 
mean + SE, n = 3]. 
In order to investigate whether increased accumu- 
lation of EPO mRNA in hepatocytes kept at 3 % 02 was 
accompanied by production and release of EPO protein, 
EPO concentrations were measured in the culture me- 
dium after 48 h of incubation at 20% O2 and 3% 02. As 
shown in Fig. 4, serial dilutions of concentrated culture 
medium showed a dose/response curve in the EPO ra- 
dioimmunoassay that paralleled that of rat serum, ver- 
ifying the presence of immunoreactive EPO protein. 
Furthermore, the EPO concentration i pooled medium 
from cultures kept at 3% O2 was approximately eight- 
fold higher than in medium from cultures at 20% 02. 
However, since concentrations of EPO protein in cell 
culture supernatant were rather low (< 10 mU/ml) and 
might not only have reflected hormone production but 
could also be influenced by variations in secretion as 
well as possibly clearance of the hormone by hepato- 
cytes, in further experiments we focussed on EPO 
mRNA determinations a a more direct measure for hyp- 
oxia-induced expression of the EPO gene. 
To test if the increase in EPO mRNA observed upon 
lowering the oxygen tension in the incubator could be 
mimicked by classical pathways of cellular activation, 
EPO mRNA levels were measured in cells kept at 20% 
O2 in the presence of certain agonists or "second-mes- 
senger" molecules. To mimic the activation of adenylate 
cyclase and guanylate cyclase, cells were incubated in 
the presence of dibutyryl-cAMP (0.01-3 mM), a mem- 
brane-permeable analogue of cyclic AMP, or 8-bromo- 
cGMP (0.01-1 mM), a membrane-permeable analogue 
of cyclic GMP. In order to stimulate adenosine receptors, 
cyclohexyladenosine (1 pM) or 5'-N-ethylcarboxami- 
doadenosine (1 gM), stable analogues of adenosine with 
preferential Al-receptor or A2-receptor affinity respec- 
tively [9], were added, and phorbol 12-myristate 13-ace- 
tate (3 nM) was used to stimulate protein kinase C ac- 
tivity [24]. However, as shown in Table 1, none of these 
substances led to a significant increase in EPO mRNA. 
At the same time, total RNA synthesis, as assessed by 
measurement of [~H]uridine incorporation into C13Ac- 
OH-insoluble material during the final 2.5 h of in- 
cubation, was unchanged or only slightly affected 
(Table 1), indicating that the failure to induce EPO 
mRNA accumulation was not due to unspecific toxicity. 
Table 1. Erythropoietin (EPO) mRNA levels and rates of total RNA synthesis in primary cultures of rat hepatocytes incubated for 18 h 
at 20% O2 in the presence of "second messengers" or agonists" 
Substance Conc. EPO mRNA gg total RNA (X 10 -4) 
Control Control 
20% O2 3% O~ 
[3H]Uridine 
incorporation 
(% of control) 
Bt2-cAMP 10 gM 0.23 + 0.43 (0.78 _+ 0.32 28.1 _+ 4.83) 86 _+ 7 
100 gM 0.0 -+ 0.66 (1.36 + 2.29 43.8 _+ 4.50) 84 _+ 4 
3 mM 2.50 _+ 2.48 (1.36 + 2.29 43.8 _+ 4.50) 77 + 4 
Forskolin 10 gM 0.70 -+ 1.02 (1.35 + 0.97 26.9 _+ 7.31) 104 + 3 
8-Br-cGMP 10 gM 1.07 + 1.55 (0.78 + 0.32 28.1 -+ 4.83) 102 _+ 4 
100 gM 0.0 -+ 0.18 (0.09 -+ 0.04 19.4 _+ 5.20) 94 +_ 1 
1 mM 0.38 -+ 0.31 (0.09 + 0.04 19.4 +_ 5.20) 96 -+ 4 
CHA 1 gM 0.0 + 1.49 (2.06 + 2.57 33.1 + 4.50) 97 -+ 2 
NECA 1 gM 0.0 + 0.92 (0.78 + 0.32 28.1 + 4.83) 106 + 5 
PMA 3 nM 1.26 + 1.12 (3.54 -4- 2.30 37.1 + 8.50) 97 + 5 
a Values are means ___ SE, n = 3. CHA, cyclohexyladenosine; NECA, 5'-N-ethylcarboxamidoadenosine; Bt2-cAMP, dibutyryl-cAMP; 
PMA, phorbol 12-myristate 13-acetate. Control cultures for EPO mRNA determinations were parallel cultures from the same cell prep- 
aration, incubated at 3% or 20% oxygen in the absence of drugs. [3H]Uridine incorporation is expressed relative to the value for controls 
incubated at 20% oxygen in the absence of drugs, which was 908 +- 36.1 cpm/dish. In cells incubated at 3 % oxygen the mean incorporation 
was 52 _+ 5% of this value 
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Fig. 5. EPO mRNA levels (upper panel) and rates of total RNA 
synthesis (lower panel) in primary cultures of rat hepatocytes incu- 
bated in the presence of divalent metals (mean +_ SE, n = 4 for 
50 pM CoClz and n = 3 for all other points). Total RNA synthesis 
was assessed as [3H]uridine incorporation i to trichloroacetic-acid- 
insoluble material during the final 2.5 h of incubation and is ex- 
pressed relative to the value in cultures incubated at 20% O~ in 
the absence of metals. O, (upper panel) EPO mRNA levels in 
parallel cultures of the same preparations, incubated at 3% O~ in 
the absence of metals. Total RNA synthesis under this condition 
was on average 44% of the value in cultures kept at 20% O~. EPO 
mRNA was quantified as described in Materials and methods and 
the legend of Fig. i 
Besides hypoxia the application of certain divalent 
metals is known to stimulate EPO formation in vivo and 
in hepatoma ceils [14-16].  As shown in Fig. 5, in ju- 
venile rat hepatocyte cultures, however, we did not ob- 
serve a major increase in EPO mRNA when cells were 
kept for 18 h at 20% 02 in the presence of nickel chlo- 
ride (50-400 gM), manganese chloride (50-600 gM) or 
cobaltous chloride (10-100 laM). Only incubation with 
50 pM cobaltous chloride and 400 ~tM nickel chloride 
led to slight, albeit significant increases in EPO mRNA 
as compared to EPO mRNA levels in parallel cultures 
from the same preparation incubated at 20% O2 in the 
absence of metals [EPO mRNA/pg total RNA (X 10-4): 
2.60 +_ 0.77 (50 gM CoCl2)  versus  0.81 + 0.64, P<0.05;  
2.01 + 0.32 (400gM NiC12) versus 0.67 +- 0.15, 
P < 0.03, mean + SE, n = 3]. In both instances, how- 
ever, EPO mRNA levels amounted to less than 7% of 
those levels observed under incubation at 3% oxygen. 
When cobaltous chloride (50-100 gM) was applied for 
48 h, no increase in EPO mRNA was observed [EPO 
mRNA/gg total RNA (•  4): 0.85 +_ 0.47 (50 gM) 
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Fig. 6. EPO mRNA levels (hatched bars) and rates of total RNA 
synthesis (open bars) in rat hepatocytes incubated in the presence 
of inhibitors of protein synthesis (cycloheximide) or haem syn- 
thesis (desferrioxamine and dioxoheptanoic acid) for 18 h at 3% 
02 (mean -+ SE, n = 3). [3H]Uridine incorporation was determined 
during the final 2.5 h. Cells were preincubated at20% 02 for 4 h 
in experiments with cycloheximide and for 24 h in experiments 
with desferrioxamine and dioxoheptanoic a id. EPO mRNA con- 
centrations and rates of total RNA synthesis are expressed relative 
to values in cultures from the same cell preparation i cubated in 
parallel at 3 % Oz in the absence of drugs. Quantification of EPO 
mRNA by RNase protection as described in Materials and methods 
and 0 - - -1 .43pg (100gM) versus 1.52_+0.28 and 
18.6 _+ 16.9 in parallel cultures kept at 20% and 3% 
oxygen, respectively, in the absence of COC12]. [3H]Urid- 
ine incorporation, as a measure of total RNA synthesis, 
was markedly reduced by MnC12 (Fig. 5, lower panel). 
COC12 and NiC12 also led to a significant, dose-depen- 
dent reduction of uridine incorporation, but the effect of 
these compounds on total RNA synthesis was much less 
pronounced, and only with 400 gM NiC12 was uridine 
incorporation lower than in cultures kept at 3% O2 in 
the absence of metals, in which it was on average 44% 
of the value in cultures incubated at 20% 02. 
In view of the hypothesis uggesting the central role 
of a rapidly turning-over haem protein in the oxygen- 
sensing mechanisms controlling EPO gene expression in 
hepatoma cells [14], we examined the effects of an in- 
hibitor of protein synthesis, of inhibitors of haem syn- 
thesis and of carbon monoxide, which were all shown to 
inhibit EPO mRNA accumulation i  Hep 3B cells [14], 
on EPO mRNA accumulation i cultured rat hepatocytes 
incubated at reduced oxygen tensions for 18 h. 
As shown in Fig. 6, the addition of the protein syn- 
thesis inhibitor cycloheximide (200 ~tM) resulted in a 
59% reduction of EPO mRNA levels. Under this con- 
dition, however, total RNA synthesis during the final 
2.5 h of incubation, as assessed by [3H]uridine incorpo- 
ration, was only 2 + 1% (mean + SE, n = 3) of the 
RNA synthesis in cultures kept at 3 % 02 in the absence 
of the drug. EPO mRNA accumulation was also in- 
hibited in the presence of desferrioxamine (130 ~tM) 
(35% reduction), an iron chelator and inhibitor of haem 
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synthesis [35] and dioxoheptanoic acid (2 mM) (79% 
reduction), an inhibitor of aminolaevulinate d hydratase 
[40]. During the final 2.5 h of incubation with these 
two compounds [3H]uridine incorporation was 
121 + 1% and 71 + 10% (mean + SE, n = 3) of the 
value observed in parallel cultures incubated at 3 % O2 
in their absence. A reduction in EPO mRNA accumu- 
lation was also observed when cells were incubated at 
1% 02 in the presence of 10% carbon monoxide, which 
is thought to block haem proteins in the oxy confor- 
mation. This reduction of EPO mRNA levels induced by 
carbon monoxide was on average 37% [EPO mRNA/pg 
total RNA (• 10-4): 11.3 + 3.1 versus 17.4 _+ 5.7, mean 
__+ SE, n = 3]. 
Discussion 
The cell fractionation experiments reported in the pre- 
sent investigation i dicate that at least two different cell 
types, hepatocytes and yet unidentified non-parenchymal 
cells, contain EPO mRNA in juvenile rat livers, but that 
in quantitative t rms hepatocytes appear to be the major 
site of EPO gene expression (Fig. 1). Although in our 
experiments we did not precisely quantify the proportion 
of EPO mRNA in parenchymal and non-parenchymal 
liver cells, this is in accordance with results from a re- 
cent study in adult rats, where similar conclusions were 
drawn from EPO mRNA measurements in liver cells 
separated by different protocols [33]. Thus, it appears 
likely that the reduction of hepatic EPO mRNA concen- 
trations that occurs with age [12], is not associated with 
a major change in cell specificity of EPO gene ex- 
pression, and that hepatocytes are at all stages of devel- 
opment he predominant production site of EPO in the 
liver. 
Our experiments indicate that the ability of hepato- 
cytes to modulate EPO production in an oxygen-depen- 
dent fashion is maintained in isolated cells in primary 
culture (Figs. 2-4).  In cells incubated at 20% O2 for 4 h 
plus 18 h EPO mRNA levels were found to decline dur- 
ing the 18-h incubation period (Fig. 2), which may re- 
flect a decay of EPO mRNA that had accumulated be- 
fore or during cell isolation, whereas, in contrast, at re- 
duced oxygen tensions, EPO mRNA levels increased 
during this period. The oxygen-dependent difference in 
EPO mRNA levels after 18 h was specific insofar as 
total RNA synthesis in hepatocytes incubated at low 
oxygen concentration (3% 02) was reduced by more 
than 50%. Moreover, it appeared to involve gene tran- 
scription, since it was abolished in the presence of acti- 
nomycin D. 
This in vitro system, demonstrating oxygen-depen- 
dent regulation of EPO mRNA in cells physiologically 
producing the hormone in vivo, may have several impli- 
cations for understanding of EPO regulation. Thus it 
suggests that oxygen-dependent control of EPO forma- 
tion in hepatocytes does not essentially require external, 
e. g. humoral, signals but that intrinsic cellular oxygen- 
sensing mechanisms exist. The concentrations of EPO 
mRNA in cultured hepatocytes were, however, lower 
than those in hepatocytes i olated from animals that 
were exposed to hypoxia in vivo (compare Figs. 1 and 
2). The progressive decrease of total RNA synthesis that 
was found with decreasing oxygen concentrations in iso- 
lated hepatocytes and the observation that EPO mRNA 
levels were slightly lower at 1% oxygen than at 3 % oxy- 
gen (Fig. 3) suggest that the level of EPO mRNA in the 
primary cultures may reflect a balance between hypoxia- 
induced gene expression and unspecific deterioration of 
cellular functions. The higher levels of EPO mRNA ach- 
ieved in vivo thus raise the possibility that in vivo exter- 
nal factors may alter this balance, e. g. by increasing the 
sensitivity of specific cellular oxygen-sensing mechan- 
isms. Alternatively disruption of tissue structure or cul- 
ture conditions might blunt the expression of EPO 
mRNA, as has been observed for other liver-specific 
genes in cultured hepatocytes [7]. However, more rel- 
evant than the absolute level of EPO mRNA in hepato- 
cyte cultures might be the relative amplitude achieved 
between incubations at ambient (20% O2) and reduced 
oxygen tensions (3% OiL which was approximately 15- 
fold under the conditions used. This amplitude of stimu- 
lation is in the same range as that observed in juvenile 
rats in vivo [12], which seems to support he suitability 
of hepatocyte cultures for study of EPO regulation. 
As a first step to identify possible signal-transduction 
mechanisms activated by hypoxia, we investigated if the 
hypoxia-induced accumulation of EPO mRNA in hepa- 
tocytes could be mimicked by the addition of classical 
"second-messenger" molecules or agonists (Table 1). 
Our results indicate, however, that neither cyclic AMP, 
cyclic GMP, adenosine or phorbol myristate acetate, 
used to stimulate protein kinase C activity [24], increase 
the amount of EPO mRNA in cells cultured at 20% oxy- 
gen. This does not support previous in vitro studies ug- 
gesting a central role of cyclic AMP in EPO regulation 
[20, 21, 30, 38], but is in accordance with observations 
in isolated perfused kidneys and hepatoma cell lines, 
where the activation of adenylate cyclase did also not 
increase basal EPO formation [14, 29, 41]. The evidence 
of a role for a short-living haem protein operating as 
oxygen sensor in the control of EPO gene expression in 
primary cultures of hepatocytes was found to be less 
conclusive than reported by Goldberg et al. for hepatoma 
cells [14]. As reported in Hep 3B cells, cycloheximide, 
dioxoheptanoic acid and desferrioxamine, substances 
proposed to interfere with the synthesis of such a haem 
protein [14, 35, 40] inhibited the hypoxia-induced in- 
creases in EPO mRNA levels of isolated hepatocytes 
(Fig. 6). However, with cycloheximide, total RNA syn- 
thesis was virtually abolished, indicating that its speci- 
ficity is low under the conditions used, and a reduction 
in total RNA synthesis in parallel with the reduction in 
EPO mRNA was also observed with desferrioxamine. 
Divalent metals, such as COC12, MnC12 and NiCI2, were 
proposed to stimulated EPO formation in Hep 3B ceils 
by replacing the central iron atom in a putative haem 
protein, thereby locking it in the oxy conformation [14]. 
When we added these metals in a wide range of dosages 
to primary cultures of hepatocytes incubated at 20% 
oxygen, a significant increase in EPO mRNA levels was 
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Table 2. Rates of L-[35S]methionine corporation (cpm/gg cellular 
protein) in primary cultures of rat hepatocytes and cultured human 
hepatoma cells (Hep G2) during an 18-h incubation at 20% oxygen 
in the absence or presence of cobaltous chloride a
CoC12 [35S]Methionine incorporation 
(cpm/gg cellular protein) 
Hep G2 cells Rat hepatocytes 
- 1159 _+ 134 592 + 71 
50 ~tM 976 -+ 45 564 _+ 46 
" Values are mean +_ SE, n = 3 
only observed with 50 ~tM CoC12 and 400 gM NiC12 and 
the values achieved were less than 7% of the EPO 
mRNA concentrations observed in parallel cultures after 
incubation at 3 % oxygen. In contrast, in Hep 3B cells 
cobalt was reported to raise EPO mRNA levels to 30%-  
50% of those values achieved under hypoxia [13, 14]. 
Our results may thus suggest hat in primary cultures of 
rat hepatocytes the in vitro response to cobalt is less well 
preserved than that to hypoxia. A failure to stimulate the 
formation of erythropoietic bioactivity with cobalt has 
previously also been observed in mixed fetal liver cul- 
tures, although these cultures did respond to hypoxia 
[21]. Moreover, although hypoxia is a consistent stimu- 
lus of hepatic EPO formation in vivo, Beru et al. found 
that treatment of adult rats with cobalt induced hepatic 
EPO mRNA accumulation only in some animals, but not 
in others [2], also indicating that the sensitivity of hep- 
atic EPO formation towards hypoxia and cobalt may di- 
verge. Following the concept of a haem protein con- 
trolling EPO gene expression, one reason for the failure 
of cobalt to stimulate isolated hepatocytes more mark- 
edly may be that the turnover of such a haem protein is 
significantly retarded in vitro, which would then not al- 
low a replacement of the ferrous iron in the centre of the 
porphyrin ring. It is worth noting in this respect that 
Goldberg et al. reported that hepatoma cells proliferate 
even in the presence of hypoxia [13], whereas in our 
experiments he cells did not divide (data not shown). In 
a first attempt o compare protein synthesis directly in 
isolated hepatocytes with that in hepatoma cells we mea- 
sured [35S]methionine incorporation in primary cultures 
of rat hepatocytes and the human hepatoma cells Hep 
G2 during 18 h incubation in the absence and presence 
of cobaltous chloride (50 ~tM). In fact, as shown in 
Table 2, [35S]methionine incorporation was lower in iso- 
lated hepatocytes than in Hep G2 cells. It is possible, 
therefore, that a haem protein may weU be involved 
in oxygen sensing in hepatocytes, but that its slow turn- 
over rate makes interference with its biosynthesis diffi- 
cult. Nevertheless it remains noteworthy that, in the 
presence of 10% carbon monoxide, which is considered 
to block haem proteins in their oxy conformation, EPO 
mRNA accumulation in hepatocytes was only reduced 
by approximately 40%, suggesting that a haem protein 
operating as oxygen sensor would either have to bind 
carbon monoxide less well than oxygen, or be respon- 
sible for only part of the rise in EPO mRNA. Interest- 
ingly in this respect, also in Hep 3B cells EPO formation 
was not totally abrogated by carbon monoxide [14]. 
In summary, using juvenile rat hepatocytes we have 
established an in vitro system of oxygen-dependent 
modulation of EPO mRNA that shows characteristics of
EPO regulation observed in vivo. EPO regulation in this 
system, although showing similarities, does not appear 
to be identical with that in permanent cell lines. Primary 
cultures of rat hepatocytes may therefore provide a valu- 
able tool for complementing the knowledge about oxy- 
gen-dependent EPO regulation. 
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